The ‘I’m just an ordinary guy’ moment that saved my life
A young man in India was diagnosed with a rare form of cancer and doctors in the country told him he would not survive another two years.
His story is a cautionary tale for anyone facing the same situation.
It was August this year, when he was diagnosed.
The 25-year-old was at his office, working on the same old set, when a colleague who worked at a hospital nearby noticed something was wrong.
“He asked me to check the lights in my office,” the young man said.
“I looked at the lights and I couldn’t see anything.
I went back in and looked at all the lights.
I said, ‘Oh my god, it’s gone!'”
The man had an operation in the hospital, but his cancer was still in his body and he died shortly afterwards.
In a country where only 4% of the population is under 30, the young woman who had been with him for a year had no idea what was wrong with him.
She said the young doctor who had cared for him at home for so long had “a very big heart”, but that he was a “normal guy” who had just made a terrible mistake.
“I didn’t know what to say,” she said.
The young man was taken to a hospital for surgery and then sent to a private hospital.
“It was horrible.
I was numb, I was so scared, I couldn´t talk,” he said.”
But my wife and I just kept telling him he could get better.”
The young doctor was diagnosed and treated at the private hospital, and the young patient had to wait for a few months to see a specialist in the Indian state of Gujarat.
In the meantime, he had to be on a waiting list for an experimental drug, called dasatinib, which was supposed to be given to patients who had cancerous tumours.
But his family could not afford to pay for the drug, and his cancer would return, almost three years later.
This is what happened to this young man.
He spent five months on the waiting list, and it was only when he finally got a positive result in December that the family finally made the decision to go ahead with the treatment.
“This is a story of how our family tried to make a life for us, but the doctors said that he is going to be fine,” the woman said.
Dasatinabin, also known as D-1, is a combination of two other drugs that the Indian government had approved in the past few years.
It is currently approved in several Indian states.
The patient’s family had been worried about their finances because they had been paying around $200 a month in rent, food and fuel, but had never had to pay that amount for treatment.
Their first doctor at the hospital did not think the drug would work, so the family decided to give it to him anyway.
The family went through a series of tests, including ultrasounds and blood tests, and he eventually developed a tumour in his spine and it grew to the size of a golf ball.
He was sent to the private Hospital for Advanced Diagnostic and Therapy of Multiple Sclerosis, or HARCOMS, where he spent three months in intensive care.
The tumour was too big to be treated, so HARCOS gave the young person a new treatment called daskar, a combination chemotherapy drug that can also be used in combination with surgery.
But when the patient had the first dose of daskad, he developed complications from the drug.
The doctors told him that he would need to stop using the drug and that they would have to stop him from getting another one for another month.
“The first week after he started taking the drug I had a few seizures, but I could hardly speak and the doctors kept telling me, ‘You have to take the drug,'” the young resident said.
But the family continued to give the drug because they believed it was the only way to save their life.
“When I told my wife, she was really scared.
She was so angry, she started crying, but she kept saying, ‘I have to do this for my son,'” the patient said.
Eventually, the family gave up on the treatment and decided to try the other option.
“We gave the drug to the family, we went to the government and we got the permission to give daskasabin,” the patient recalled.
The government approved the drug in September, and in the next few months, the hospital began to receive more and more patients from all over India who were suffering from the same cancer.
By November, they had seen more than 20,000 patients with cancer and almost every day they saw at least three more patients who also had cancer.
The patients were sent to HARCOC, a private facility in Mumbai, to be seen by a doctor.
But they were not allowed to leave the hospital.
“We were told by the doctors that we could not leave the facility